CRP and hepatocellular carcinoma: To identify the relationship between clinicopathological factors and the PFS of HCC patients treated with PD-1 inhibitors, univariate Cox proportional models were used, which identified elevated serum CRP, NLR and AFP levels as possible prognostic factors for the PFS of HCC patients.